4.5 Article

Bactericidal impact of Ag, ZnO and mixed AgZnO colloidal nanoparticles on H37Rv Mycobacterium tuberculosis phagocytized by THP-1 cell lines

期刊

MICROBIAL PATHOGENESIS
卷 110, 期 -, 页码 335-344

出版社

ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.micpath.2017.07.010

关键词

Mycobacteria; Antimicrobials; Cytotoxicity; Resistance; Infection

向作者/读者索取更多资源

The purpose of this research project was to infection of human macrophages (THP-1) cell lines by H(37)Rv strain of Mycobacterium tuberculosis (H(37)RvMTB) and find out the ratio/dilution of mixture silver (Ag NPs) and zinc oxide nanoparticles (ZnO NPs) whose ability to eliminate phagocytized bacteria compared to rifampicin. The colloidal Ag NPs and ZnO NPs were synthesized and their characteristics were evaluated. The THP-1 cell lines were infected with different concentration of H(37)RvMTB. Next, the infected cells were treated with different ratios/dilutions of Ag NPs, ZnO NPs and rifampicin. The THP-1 were lysed and were cultured in Lowenstein-Jensen agar medium, for eight weeks. The TEM and AFM images of NPs and H37RvMTB were supplied. It is observed that Ag NPs, 2(Ag):8(zno) and 8(Ag):2(zno) did not have any anti tubercular effects on phagocytized H(37)RvMTB. Conversely, ZnO NPs somehow eliminated 18.7 x 10(4) CFU ml(-1) of H(37)RvMTB in concentration of similar to 0.468 ppm. To compare with 40 ppm of rifampicin, similar to 0.663 ppm of 5(Ag):5(zno) had the ability to kill of H(37)RvMTB, too. Based on previous research, ZnO NPs had strong anti-tubercular impact against H37RvMTB to in -vitro condition, but it was toxic in concentration of similar to 0.468 ppm to both of THP-1 and normal lung (MRC-5) cell lines. It also seems that 5(Ag):5(zno) is justified because in concentration of similar to 0.663 ppm of 5(Ag):5(zno), phagocytized H(37)RvMTB into the THP-1 had died without any toxicity effects against THP-1 and also MRC-5 cell lines. It is obvious that the mixture of colloidal silver and zinc oxide NPs with ratio of 5(Ag):5(zno) would be trustworthy options as anti -tubercular nano-drugs in future researches. (C) 2017 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据